Want to see HK:1112 full AI Analyst Report?
1112 Stock Chart & Stats
HK$18.44
-HK$0.20(-1.37%)
At close: 4:00 PM EDT
HK$18.44
-HK$0.20(-1.37%)
Day’s Range― - ―
52-Week RangeHK$10.10 - HK$20.18
Previous CloseN/A
Volume1.46M
Average Volume (3M)2.68M
Market Cap
HK$12.46B
Enterprise ValueHK$13.15B
Total Cash (Recent Filing)HK$1.99B
Total Debt (Recent Filing)HK$7.72B
Price to Earnings (P/E)14.7
Beta0.65
Next Earnings
Mar 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.94%
Share Statistics
EPS (TTM)1.15
Shares Outstanding645,561,340
10 Day Avg. Volume1,488,850
30 Day Avg. Volume2,680,785
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.26
Price to Sales (P/S)0.53
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$24.30Price Target Upside31.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.54
Revenue Forecast (FY)HK$16.97B
Bulls Say, Bears Say
Bulls Say
Diversified Branded Nutrition PortfolioExposure to multiple nutrition and wellness categories gives H&H a broader platform for consumer demand than a single-product business. Its branded products and established online and offline channels can support repeat purchases, cross-selling, and durable market presence over the coming quarters.
Strong Gross-margin EconomicsGross margins in the 60–64% range indicate meaningful value capture from the branded product portfolio after direct costs. This creates room to fund marketing, distribution, and product development, while providing some resilience if channel costs or input expenses remain elevated.
Consistently Positive Free Cash FlowSustained positive free cash flow demonstrates that the business converts reported earnings into cash and retains internal funding capacity. The approximately HK$0.95B generated in 2025 can support operations, investment, and gradual balance-sheet improvement without relying entirely on external financing.
Bears Say
Volatile Bottom-line ProfitabilityA loss followed by only a 1.4% net margin indicates that revenue and gross-margin strength have not translated consistently into shareholder earnings. Persistent earnings volatility can restrict reinvestment, weaken returns, and make financial performance less dependable over the next several quarters.
Elevated Leverage And Weaker ReturnsLeverage around 1.5 times equity reduces financial flexibility when profitability is uneven, while the decline in ROE to about 3% shows weaker capital productivity. Together, these conditions increase sensitivity to earnings setbacks and may constrain future capital-allocation choices.
Modest Deleveraging CapacityAlthough cash generation remains positive, its 2025 decline and low operating-cash-flow coverage relative to debt suggest that deleveraging may be gradual. This limits the speed at which H&H can reduce balance-sheet risk and leaves less flexibility if earnings or cash flow weaken further.
Health and Happiness (H&H) International Holdings News
1112 FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was HK$10.10 and its highest was HK$20.18 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is HK$12.46B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Mar 23, 2027 which is in 165 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Aug 25, 2026. The company reported HK$1.674 earnings per share for the quarter.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited pays a Semiannually dividend of HK$0.82 which represents an annual dividend yield of 4.94%. See more information on Health and Happiness (H&H) International Holdings Limited dividends here
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of HK$1.674 in its last earnings report. Following the earnings report the stock price went down -0.268%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in HK:1112
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health and Happiness (H&H) International Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$24.30 (31.76% Upside)
HK$24.30 (31.76% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.99%
12-Months-Change
Fundamentals
Return on Equity
11.77%
Trailing 12-Months
Asset Growth
6.09%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Health and Happiness (H&H) International Holdings Limited
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (1112) Earnings & Revenues
1112 Company Deck
1112 Earnings Call
Q2 2026
0:00 / 0:00
1112 Stock 12 Month Forecast
Average Price Target
HK$24.30
▲(31.76% Upside)
Technical Analysis
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―